BioCorRx (BICX) Non-cash Items (2017 - 2026)

BioCorRx has disclosed Non-cash Items across 10 years of filings, most recently posting $1.7 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed N/A YoY), and the FY2025 annual result was $1.7 million, changed N/A from the prior year.
• Non-cash Items came in at $1.7 million for Q1 2026 at BioCorRx, roughly flat from $1.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $1.8 million in Q4 2023 to a low of $831138.0 in Q1 2022.
• The 5-year median for Non-cash Items is $887901.0 (2023), against an average of $1.2 million.
• Across the five-year window, Non-cash Items rose 2.1% in 2022 and jumped 103.73% in 2023, its largest moves.
• BioCorRx's Non-cash Items stood at $866766.0 in 2022, then surged by 103.73% to $1.8 million in 2023, then plunged by 47.11% to $934026.0 in 2024, then soared by 78.7% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• The last three Non-cash Items figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.